NJCMCS

Partners And Sponsors

With strong encouragement and initial support from our industrial and government laboratory collaborators as well as neighboring academic institutions, we have been able to accomplish significant initial progress in many aspects. We have been able to formulate three people-sharing partnerships and attract substantial initial federal and state funding commitments. With this momentum being built and with the requested support from the State, our strategy is to vertically integrate the core knowledge base with concept demonstrations aimed for commercialization with our industrial partners. Our key industrial partners to date include Bristol Myers Squibb, FMC Corporation, Lucent-New Jersey Nanotechnolgy Center, and Army-Picatinny Arsenal, and Sarnoff Corporation which represent the nation’s pharmaceutical, chemical, microsystems, and defense industries.

Summary of the Center’s Current Research Partnerships

	On-demand H2 for Portable Power	On-demand H2O2 via Direct H2/O2 Combination	On-demand Hydrogenation of Pharmaceutical Molecules
Partner(s)	Sarnoff	FMC	BMS, Lucent, ChemProcess
Collaborator(s)	Cornell, Lucent, NJIT	ERM, Sarnoff	UConn
Start Date	09/2002	09/2002	10/2003
Sponsor(s)	Army, NJCST, DARPA	DOE-OIT, NJCST	DOE-OIT, NJCST

We recognize significant opportunity for high-tech business creation based on the anticipated results of our partnership projects. For this purpose, the New Jersey Commission on Science and Technology (NJCST) has helped to establish the Center for the past two years with a planning grant with emphasis on linking our Center activities to jobs growth and economic development of the State and the region. The U.S. Department of Energy–Office of Industrial Technologies (DOE-OIT) is currently supporting two of our partnerships. This office is interested in the energy saving aspects of our research activities as summarized in Table 1. Army-Picatinny Arsenal is our strategic partner as well as a major sponsor.

We plan to capture and extend the experience generated by the above partnerships as a creative and sustainable mechanism for creating additional research partnerships that would help expand the technical depth and scope of the Center with particular emphasis on biomedical and pharmaceutical relevant microreactor devices and microchemical systems.